Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2296442 | 0.74 | — | — | |
| SCHEMBL11430568 | 0.74 | FFAR3 (0.36) | PYGM | |
| SCHEMBL10823577 | 0.73 | DAO (0.32) | PYGM | |
| SCHEMBL8781919 | 0.71 | — | — | |
| SCHEMBL168735 | 0.67 | PYGM (0.35) | PYGM | |
| SCHEMBL1428318 | 0.67 | PYGM (0.35) | PYGM | |
| SCHEMBL1286030 | 0.67 | PYGM (0.35) | PYGM | |
| SCHEMBL10363649 | 0.67 | — | — | |
| SCHEMBL1165189 | 0.67 | HCAR2 (0.33) | — | |
| SCHEMBL10823560 | 0.67 | PYGM (0.31) | PYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-56147749-A | — | — | None | — | — | JP | disclosed |
| EP-4719381-A1 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. (TW) | 2026-04-08 | — | — | EP | disclosed |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | TRIPARTITE THERAPEUTICS INC. (TW) | 2025-01-30 | — | — | US | disclosed |
| JP-2008127321-A | METHOD FOR PRODUCING DIGLYCYLTEREPHTHALIC ACID COMPOUND | TOYOBO CO LTD | 2008-06-05 | — | — | JP | disclosed |
| CN-1300140-C | Compound of quinacridones-carbazole group and application in organic electroluminescence device | UNIV JILIN (CN) | 2007-02-14 | — | — | CN | disclosed |
| CN-1219778-C | Quinacridone derivant and application in organic electroluminescent device thereof | UNIV JILIN (CN) | 2005-09-21 | — | — | CN | disclosed |
| CN-1660844-A | Compound of quinacridones-carbazole group and application in organic electroluminescence device | UNIV JILIN (CN) | 2005-08-31 | — | — | CN | disclosed |
| US-20050118454-A1 | Luminescent compound emitting white light, illuminator and organic el element emitting white light | HIROSE ENGINEERING CO., LTD. (JP) | 2005-06-02 | — | — | US | disclosed |
| EP-1475380-A1 | WHITE LIGHT EMITTING COMPOUND, WHITE LIGHT EMISSION ILLUMINATOR, AND WHITE LIGHT EMISSION ORGANIC EL DEVICE | HIROSE ENGINEERING CO., LTD. (JP) | 2004-11-10 | — | — | EP | disclosed |
| CN-1482127-A | Quinacridone derivant and application in organic electroluminescent device thereof | 吉林大学 | 2004-03-17 | — | — | CN | disclosed |
| EP-0764630-B1 | Process for the preparation of dialkyl succinylsuccinates | CIBA SC HOLDING AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-5783723-A | REACTING AN ALKALI METAL ALCOHOLATE WITH AN EXCESS OF DIALKYL SUCCINATE UNDER ANHYDROUS CONDITIONS FOLLOWED BY ISOLATION OF THE DI(ALKALI METAL) SALT OF THE DIALKYL SUCCINYLSUCCINATE; CYCLIZATION; NEUTRALIZATION | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-07-21 | — | — | US | disclosed |
| EP-0764630-A1 | Process for the preparation of dialkyl succinylsuccinates | Ciba SC Holding AG (CH) | 1997-03-26 | — | — | EP | disclosed |
| JP-S56147749-A | PREPARATION OF SUCCINOSUCCINIC ACID DIALKYL ESTER | UBE IND LTD | 1981-11-16 | — | — | JP | disclosed |
| US-4244842-A | Nickel and cobalt chelate complexes and their use | CIBA-GEIGY CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050118454-A1 | Luminescent compound emitting white light, illuminator and organic el element emitting white light | ELP1, ERG, LEF1 | PYGM 3427/4885 |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | CD274, SELPLG, PDCD1LG2 | PYGM 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.